REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company offers educational content, insurance services, and the Aidity System to support pharmacists and pharmaceutical staff. It aims to strengthen the pharmaceutical industry and ensure the continuity of healthier pharmaceutical operations. The target market includes pharmacists and pharmaceutical staff, and the company operates in the pharmaceutical industry.

Headquarters
No:3 Merkez Mahallesi Sedir Sokak Bahcelievler
Istanbul; Marmara; Postal Code: 34188

Contact Details: Purchase the Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi report to view the information.

Website: http://www.iskoop.org

Basic Information
Total Employees:
Purchase the Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi report to view the information.
Outstanding Shares:
Purchase the Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi report to view the information.
Incorporation Date:
July 17, 1989
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Sinirli Sorumlu Istanbul Eczacilar Uretim Temin Dagitim Kooperatifi report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
85.21%
Total operating revenue
85.21%
Operating profit (EBIT)
39.49%
Net Profit (Loss) for the Period
8.72%
Total assets
78.5%
Total equity
70.69%
Operating Profit Margin (ROS)
-1.07%
Net Profit Margin
-1.37%
Return on Equity (ROE)
-17.34%
Debt to Equity Ratio
-12.43%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?